Search Results - "Scardino, E"

Refine Results
  1. 1

    Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection by Petralia, G., Villa, G., Scardino, E., Zoffoli, E., Renne, G., de Cobelli, O., Bellomi, M.

    Published in Radiologia medica (01-06-2008)
    “…Purpose This study was undertaken to compare the local staging of penile cancer by magnetic resonance imaging (MRI) combined with pharmacologically induced…”
    Get full text
    Journal Article
  2. 2

    Magnetic resonance imaging combined with artificial erection for local staging of penile cancer by Scardino, E., Villa, G., Bonomo, G., Matei, D.V., Verweij, F., Rocco, B., Varela, R., de Cobelli, O.

    Published in Urology (Ridgewood, N.J.) (01-06-2004)
    “…To assess magnetic resonance imaging (MRI) combined with artificial erection for local staging of penile cancer. We compared local clinical, MRI plus…”
    Get full text
    Journal Article
  3. 3

    Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer by Spitaleri, G., Matei, D. V., Curigliano, G., Detti, S., Verweij, F., Zambito, S., Scardino, E., Rocco, B., Nolè, F., Ariu, L., De Pas, T., de Braud, F., De Cobelli, O.

    Published in Annals of oncology (01-03-2009)
    “…Background: There is a need for active agents with a better safety profile than docetaxel, yet good activity, for patients with hormone-refractory prostate…”
    Get full text
    Journal Article
  4. 4

    Vinorelbine-based Chemotherapy in Hormone-refractory Prostate Cancer by ZAMPINO, M. G, VERRI, E, DECOBELLI, O, GOLDHIRSCH, A, NOLE, F, LOCATELLI, M, CURIGLIANO, G, ASCIONE, G, SBANOTTO, A, ROCCA, A, VERWEIJ, F, MATEI, V, SCARDINO, E

    Published in Anticancer research (01-05-2006)
    “…Background: No consensus exists regarding further therapy for the management of hormone-refractory prostate cancer. In this phase II study, the combination of…”
    Get full text
    Journal Article
  5. 5

    Gn-RH Antagonist Possible Response, After Gn-RH Agonist Failure in a Man with Metastatic Prostate Cancer by ROCCO, B, FERRARI, M, SCARDINO, E, MATEI, D. V, VERWEIJ, F, VARELA, R, DE COBELLI, O

    Published in Anticancer research (01-01-2005)
    “…Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical…”
    Get full text
    Journal Article
  6. 6

    Late solitary thyroid carcinoma metastasis to the kidney: a case report by Matei, D V, Verweij, F, Scardino, E, Rocco, B, Renne, G, Tradati, N, De Cobelli, O

    Published in Anticancer research (01-01-2003)
    “…Secondary tumour to the kidney is quite frequent. Even if, theoretically, all solid tumours may give rise to renal metastasis, secondary lesions to the kidney…”
    Get more information
    Journal Article
  7. 7

    Spermatic cord liposarcoma: a report of four cases by Matei, D V, Rocco, B, Scardino, E, Verweij, F, Renne, G, Fasani, R, De Cobelli, O

    Published in Anticancer research (01-05-2003)
    “…Spermatic cord liposarcoma is a rare pathology (1-4); currently about one hundred cases are documented. The therapy of choice is surgery, followed sometimes by…”
    Get more information
    Journal Article
  8. 8

    Reversal of clinical resistance to LHRH analogue in metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH analogue plus melatonin in patients progressing on LHRH analogue alone by Lissoni, P, Cazzaniga, M, Tancini, G, Scardino, E, Musci, R, Barni, S, Maffezzini, M, Meroni, T, Rocco, F, Conti, A, Maestroni, G

    Published in European urology (01-01-1997)
    “…Experimental and preliminary clinical studies have suggested that the pineal hormone melatonin (MLT) may stimulate hormone receptor expression on both normal…”
    Get more information
    Journal Article
  9. 9

    Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell carcinoma by Lissoni, P, Barni, S, Ardizzoia, A, Crispino, S, Paolorossi, F, Andres, M, Scardino, E, Tancini, G

    Published in Oncology (01-01-1994)
    “…The intravenous immunotherapy with interleukin 2 (IL-2) represents one of the most active therapies of metastatic renal cell carcinoma (RCC). Recently, it has…”
    Get more information
    Journal Article
  10. 10

    Antidote-mediated control of an anticoagulant aptamer in vivo by Rusconi, Christopher P, Sullenger, Bruce A, Roberts, Joseph D, Pitoc, George A, Nimjee, Shahid M, White, Rebekah R, Quick, George, Scardino, Elizabeth, Fay, William P

    Published in Nature biotechnology (01-11-2004)
    “…Patient safety and treatment outcome could be improved if physicians could rapidly control the activity of therapeutic agents in their patients. Antidote…”
    Get full text
    Journal Article
  11. 11

    Generation of Species Cross-reactive Aptamers Using “Toggle” SELEX by White, Rebekah, Rusconi, Christopher, Scardino, Elizabeth, Wolberg, Alisa, Lawson, Jeffrey, Hoffman, Maureane, Sullenger, Bruce

    Published in Molecular therapy (01-12-2001)
    “…Species cross-reactivity facilitates the preclinical evaluation of potentially therapeutic molecules in animal models. Here we describe an in vitro selection…”
    Get full text
    Journal Article
  12. 12

    RNA aptamers as reversible antagonists of coagulation factor IXa by Rusconi, Christopher P, Sullenger, Bruce A, Scardino, Elizabeth, Layzer, Juliana, Pitoc, George A, Ortel, Thomas L, Monroe, Dougald

    Published in Nature (London) (05-09-2002)
    “…Many therapeutic agents are associated with adverse effects in patients. Anticoagulants can engender acute complications such as significant bleeding that…”
    Get full text
    Journal Article
  13. 13

    A randomized study of low-dose interleukin-2 subcutaneous immunotherapy versus interleukin-2 plus interferon-alpha as first line therapy for metastatic renal cell carcinoma by Lissoni, P, Barni, S, Ardizzoia, A, Andres, M, Scardino, E, Cardellini, P, Della Bitta, R, Tancini, G

    Published in Tumori (31-12-1993)
    “…IL-2 given subcutaneously in combination with interferon-alpha 2b (IFN) appears to induce a response rate comparable to that obtained with IL-2 intravenous…”
    Get more information
    Journal Article
  14. 14

    Correlation between pretreatment serum levels of neopterin and response to interleukin-2 immunotherapy in cancer patients by Lissoni, P, Barni, S, Ardizzoia, A, Scardino, E, Tancini, G, Viganò, M G

    “…IL-6 levels have been proven to correlate with resistance to IL-2 immunotherapy. Since IL-6 may be produced by both macrophages and TH2 lymphocytes, it is not…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Lymphocytosis decline is not responsible for tumor progression in cancer patients chronically treated with interleukin-2 by Lissoni, P, Barni, S, Andres, M, Scardino, E, Vigoré, L, Vezzo, R, Rescaldani, R, Tancini, G

    Published in Tumori (31-08-1994)
    “…The antitumor activity of IL-2 is mediated by an increase in lymphocyte number. Moreover, our previous studies have shown that therapy for 1 week/month with…”
    Get more information
    Journal Article
  18. 18

    Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report by Rocco, Bernardo, de Cobelli, Ottavio, Leon, Maria Elena, Ferruti, Mario, Mastropasqua, Mauro G., Matei, Deliu Victor, Gazzano, Giacomo, Verweij, Fabrizio, Scardino, Epifanio, Musi, Gennaro, Djavan, Bob, Rocco, Francesco

    Published in European urology (01-05-2006)
    “…The various prostate biopsy methods are usually compared in terms of the diagnosis rate of prostate cancer. However, the prevalence of cancer in patients with…”
    Get full text
    Journal Article
  19. 19

    Synchronous Collecting Duct Carcinoma and Papillary Renal Cell Carcinoma: A Case Report and Review of the Literature by MATEI, Deliu-Victor, ROCCO, Bernardo, VARELA, Rodolfo, VERWEIJ, Fabrizio, SCARDINO, Epifanio, RENNE, Giuseppe, DE COBELLI, Ottavio

    Published in Anticancer research (01-01-2005)
    “…The coexistence of multiple and synchronous primary neoplasms in the same organ (including kidney) has only rarely been described in the literature. We herein…”
    Get full text
    Journal Article
  20. 20

    Localization of Avidin in Superficial Bladder Cancer: A Potentially New Approach for Radionuclide Therapy by Chinol, Marco, De Cobelli, Ottavio, Trifirò, Giuseppe, Scardino, Epifanio, Bartolomei, Mirco, Verweij, Fabrizio, Papi, Stefano, Matei, Deliu V., Paganelli, Giovanni

    Published in European urology (01-11-2003)
    “…Objective: To verify whether native avidin, made radioactive through the binding with technetium-99m labeled biotin ( 99 m Tc -biotin), selectively accumulated…”
    Get full text
    Journal Article